NDC 0338-0112 – Norepinephrine Bitartrate

Norepinephrine Bitartrate 4 mg/250mL · Injection, Solution · Intravenous

Human Prescription Drug 1 recall

Product NDC0338-0112

Product details

Brand name
Norepinephrine Bitartrate
Generic name
Norepinephrine bitartrate
Labeler
Baxter Healthcare Corporation
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
NDA · NDA214313
Marketed since
January 15, 2021
Listing expires
December 31, 2027
Pharmacologic class
Catecholamine

Active ingredients

Uses, dosage, side effects and warnings for Norepinephrine Bitartrate →

Package NDC codes (1)

Package NDCDescriptionSince
0338-0112-2020 BAG in 1 CARTON (0338-0112-20) / 250 mL in 1 BAGJan 15, 2021

Recalls mentioning this NDC

Other Norepinephrine Bitartrate products